Aave Proposes Restructuring of Its Bug Bounty Program, with the Top Bounty for Core Aave V3 Increasing to $5M

iconKuCoinFlash
Share
This is the logo of the coin.
AAVE
$154.17-4.13%
AI summary iconSummary
Aave Proposes Restructuring of Its Bug Bounty Program, with Core Aave V3’s Top Bounty Rising to $5M. This leading altcoin news highlights a major protocol update, as Aave Labs plans to divide the bounty program into multiple modules managed by Immunefi, Sherlock, and Cantina. The top reward for critical Aave V4 bugs increases to $2.5M, while the maximum bounty for Core Aave V3 rises to $5M. The Aave DAO will now oversee the Aave V3 on Aptos bug bounty program, with a performance review scheduled for 6–12 months.

BlockBeats report, on May 15, Aave Labs proposed restructuring the Aave DAO bug bounty program by splitting different protocol modules into separate bounty initiatives, each operated by Immunefi, Sherlock, and Cantina. The maximum bounty for critical vulnerabilities in Aave V4 is proposed to increase from $500,000 to $2.5 million, while the maximum bounty for critical vulnerabilities in core Aave V3 is proposed to rise from $1 million to $5 million.


The proposal also plans to transfer responsibility for the Aave V3 on Aptos bug bounty funds from Aave Labs to the Aave DAO, and to evaluate the performance of the multi-platform parallel model over the next 6 to 12 months.

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.